Is Systemic Node Dissection for Accuracy Staging in Clinical Stage I Non-Small Cell Lung Cancer Worthwhile in the Elderly?

Abstract

Objective: The therapeutic role of systematic node dissection (SND) for early lung cancer remains controversial. Elderly patients have a background of insufficient physiological function and comorbidity, and a shorter life expectancy than that of younger patients. Therefore, we have evaluated the impact on survival, local recurrence, and complications of not performing systematic lymph node dissection in the elderly. Methods: A retrospective analysis of 126 patients, including the elderly (75 - 89 years), who underwent a lobectomy for clinical stage I was performed. The patients were grouped according to node dissection numbers after surgery, and finally separated into two groups (SG: sufficient group, dissections of more than 10 nodes and 3 or more mediastinal stations; IG: insufficient group, less than 10 nodes and one or two mediastinal stations). Postoperative morbidity and sites of recurrence were evaluated between the two groups, and the survival rates were analyzed at 5 years. Results: Upstage was identified in 12.6 % of patients: 7.3 % in IG (n = 45), 15.2 % in SG (n = 86). Postoperative mortality occurred in 2 cases (1.58 %). The incidence of postoperative respiratory or cardiac complications was more frequent in the SG, while there were fewer complications in the IG. There was no significant difference in recurrence rates between the two groups. Both local and distant recurrence was observed in the two groups. The 5-year survival rates were 61.5 % for the SG and 59.4 % for the IG. There was no significant difference in the survival rate between the IG and SG patients. Conclusions: Proper staging and the avoidance of nontherapeutic lymph node dissection seems acceptable for clinical stage I lung cancer in the group of elderly patients.

Key words

thoracic surgery - elderly age - lymph node dissection - lung cancer

References

• 1 Wright G, Manser R L, Byrnes G, Hart D, Campbell D A. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials.  Thorax. 2006;  61 597-603
• 2 Wu Y, Huang Z F, Wang S Y, Yang X N, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.  Lung Cancer. 2002;  36 1-6
• 3 Feinstein A R, Sosin D M, Wells C K. The Will Rogers phenomenon. Stage migration and new diagnosis techniques as a source of misleading statistics for survival in cancer.  N Engl J Med. 1985;  312 1604-1608
• 4 American Joint Committee on Cancer .AJCC Cancer Staging Manual. 6th edn. New York; Springer 2002
• 5 Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, Giudicelli R, Fuentes P, Thomas P. Does the extend of lymph node dissection influence outcome in patients with stage I non-small cell cancer?.  Eur J Cardiothorac Surg. 2005;  27 680-685
• 6 Cardinale D, Martinoni A, Cipolla C M, Civelli M, Lamantia G, Fiorentini C, Mezzetti M. Atrial fibrillation after operation for lung cancer: clinical and prognostic significance.  Ann Thorac Surg. 1999;  68 1827-1831
• 7 Hirata T, Koizumi K, Tanaka S. Changes in hemodynamics in patients who underwent extended mediastinal lymphadenectomy through median sternotomy for primary lung cancer.  Jpn J Thorac Cardiovasc Surg. 2003;  51 178-185
• 8 Ludwig M S, Goodman M, Miller D L, Johnstone P A. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.  Chest. 2005;  128 1545-1550
• 9 Rostad H, Naalsund A, Strand T E, Jacobsen R, Talleraas O, Norstein J. Results of pulmonary resection for lung cancer in Norway, patients older than 70 years.  Eur J Cardiothorac Surg. 2005;  27 325-328
• 10 Birim O, Zuydendorp H M, Maat A P, Kappetein A P, Eijkemans M J, Bogers A J. Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population.  Ann Thorac Surg. 2003;  76 1796-1801
• 11 Allen M S, Darling G E, Pechet T T, Mitchell J D, Herndon 2nd J E. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.  Ann Thorac Surg. 2006;  81 1013-1019
• 12 Fukuse T, Satoda N, Hijiya K, Fujinaga T. Importance of comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients.  Chest. 2005;  127 886-891
• 13 Gajra A, Newman N, Gamble G P, Kohman L J, Graziano S L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.  J Clin Oncol. 2003;  21 1029-1034
• 14 Ito M, Minamiya Y, Kawai H, Saito S, Saito H, Imai K, Ogawa J. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.  J Thorac Cardiovasc Surg. 2005;  130 753-758
• 15 Ishiwa N, Ogawa N, Shoji A, Maehara T, Hayashi Y, Takanashi Y, Yazawa T, Ito T. Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas, in considering the indication of limited surgery.  Lung Cancer. 2003;  39 159-164
• 16 Rzyman W, Hagen O M, Dziadziuszko R, Kobierska-Gulida G, Karmolinski A, Lothe I M, Babovic A, Murawski M, Paleczka W, Jastrzebski T, Kopacz A, Jassem J, Lass P, Skokowski J. Intraoperative, radio-guided sentinel lymph node mapping in 110 non-small cell lung cancer patients.  Ann Thorac Surg. 2006;  82 237-242
• 17 Pulte D, Li E, Crawford B K, Newman E, Alexander A, Mustalish D C, Jacobson D R. Sentinel lymph node mapping and molecular staging in non-small cell lung carcinoma.  Cancer. 2005;  104 1453-1461
• 18 Yoshimasu T, Miyoshi S, Oura S, Hirai I, Kokawa Y, Okamura Y. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations.  J Thorac Cardiovasc Surg. 2005;  130 433-437
• 19 Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.  Ann Thorac Surg. 2006;  81 1028-1033
• 20 Halpern B S, Schiepers C, Weber W A, Crawford T L, Fueger B J, Phelps M E, Czernin J. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.  Chest. 2005;  128 2289-2297
• 21 Iwasaki A, Shirakusa T, Shiraishi T, Yamamoto S. Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer.  Eur J Cardiothorac Surg. 2004;  26 158-164
• 22 McKenna Jr R J, Houck W, Fuller C B. Video-assisted thoracic surgery lobectomy: experience with 1100 cases.  Ann Thorac Surg. 2006;  81 421-425
• 23 McVay C L, Pickens A, Fuller C, Houck W, McKenna Jr R J. VATS anatomic pulmonary resection in octogenarians.  Am Surg. 2005;  71 791-793